CEFOXITIN AS A SINGLE-DOSE TREATMENT FOR URETHRITIS CAUSED BY PENICILLINASE-PRODUCING NEISSERIA-GONORRHOEAE
CEFOXITIN AS A SINGLE-DOSE TREATMENT FOR URETHRITIS CAUSED BY PENICILLINASE-PRODUCING NEISSERIA-GONORRHOEAE
复制标题
DOI:
10.1056/nejm197909063011001
复制
发表时间:
1979-01-01
影响因子:
158.5
通讯作者:
MCCUTCHAN, JA
中科院分区:
文献类型:
--
作者:
BERG, SW;KILPATRICK, ME;MCCUTCHAN, JA
Gonococci that resist standard penicillin regimens by production of a penicillinase are now well established in certain areas of the world. Because cefoxitin, a semisynthetic cephamycin, resists gonococcal penicillinase in vitro, procaine penicillin G and cefoxitin were compared in treatment of gonorrhea in an area where 40% of isolates produce penicillinase. Men [107] with culture-proved gonococcal urethritis were given a single dose of either procaine penicillin G, 4.8 million U, or cefoxitin, 2 g, i.m. Both groups took 1 g of probenecid orally; cefoxitin was given with lidocaine to reduce pain at the injection site. In men infected with penicillinase-negative gonococci, both cefoxitin and penicillin were highly effective. Penicillin failed in 77% of men with penicillinase-positive strains, whereas cefoxitin was completely successful. Cefoxitin is an effective alternative to spectinomycin for single-session therapy of urethritis caused by penicillinase-producing N. gonorrhoeae.